Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis-Reference-Cited by-同舟云学术

Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis

Author:

Cortesi P. A.¹,Mantovani L. G.²,Ciaccio A.³,Rota M.⁴,Mazzarelli C.⁵,Cesana G.¹,Strazzabosco M.³⁶,Belli L. S.⁵

Affiliation:

1. Research Centre on Public Health (CESP); University of Milan-Bicocca; Monza Italy

2. Department of Clinical Medicine and Surgery; University Federico II of Naples; Naples Italy

3. Department of Surgical and Interdisciplinary Medicine; University of Milan-Bicocca; Monza Italy

4. Department of Health Sciences, Centre of Biostatistics for Clinical Epidemiology; University of Milan-Bicocca; Monza Italy

5. Department of Hepatology and Liver Unit; Niguarda Hospital; Milan Italy

6. Liver Center & Section of Digestive Diseases, Department of Internal Medicine; Yale University School of Medicine; New Haven CT

Funder

NIH

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference27 articles.

2. https://trapianti.sanita.it/statistiche/home.asp

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献